DS
NVO

David Shaw’s Novo Nordisk NVO Stock Holding History

David Shaw’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134M Buy
2,796,700
+1,366,600
+96% +$58.7M 0.06% 331
2026
Q1 		$52.6M Buy
1,430,100
+497,000
+53% +$23.5M 0.03% 634
2025
Q4 		$47.5M Buy
933,100
+716,500
+331% +$36.6M 0.03% 734
2025
Q3 		$12M Buy
216,600
+94,000
+77% +$5.5M 0.01% 1536
2025
Q2 		$8.46M Buy
122,600
+76,700
+167% +$5.22M 0.01% 1622
2025
Q1 		$3.19M Sell
45,900
-59,900
-57% -$4.95M ﹤0.01% 2245
2024
Q4 		$9.1M Buy
105,800
+15,300
+17% +$1.65M 0.01% 1567
2024
Q3 		$10.8M Sell
90,500
-119,000
-57% -$15.9M 0.01% 1383
2024
Q2 		$29.9M Buy
209,500
+186,500
+811% +$24.7M 0.03% 673
2024
Q1 		$2.95M Sell
23,000
-11,500
-33% -$1.37M ﹤0.01% 2318
2023
Q4 		$3.57M Buy
34,500
+31,100
+915% +$3.08M ﹤0.01% 2191
2023
Q3 		$309K Hold
3,400
– – ﹤0.01% 3600
2023
Q2 		$275K Buy
+3,400
New +$278K ﹤0.01% 3629
2014
Q2 		– Sell
-52,800
Closed -$1.21M – 4428
2014
Q1 		$1.21M Buy
+52,800
New +$1.12M ﹤0.01% 2861
2013
Q3 		– Sell
-200,000
Closed -$3.1M – 4404
2013
Q2 		$3.1M Buy
+200,000
New +$3.33M 0.01% 1715

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

David Shaw's NVO Position: Q2 2026 in Review

David Shaw reduced its Novo Nordisk (NVO) stake by 66% in Q2 2026, selling an estimated $57.6M and leaving 697,567 shares worth $33.4M. The position accounts for 0.02% of the portfolio, ranked #983.

David Shaw first reported a position in NVO in Q2 2013 and has held it in 40 quarters since. The position peaked at $179M in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • David Shaw held 697,567 shares of Novo Nordisk worth $33.4M as of Q2 2026.
  • David Shaw sold 1,341,539 Novo Nordisk shares in Q2 2026, an estimated $57.6M.
  • Novo Nordisk made up 0.02% of David Shaw's portfolio in Q2 2026, its #983 holding.
  • David Shaw first reported a position in Novo Nordisk in Q2 2013 and has held it in 40 quarters since.
  • David Shaw's Novo Nordisk position peaked at $179M in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.